Alpine Global Management, LLC Abb Vie Inc. Transaction History

Alpine Global Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 06, 2024	BUY	$159.82 - $182.1 $244,364 - $278,430	1,529 New	1,529 $278,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $1.7 Million - $2.04 Million	-27,000 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $1.77 Million - $2.27 Million	27,000 New	27,000 $1.96 Million

3,958

1.26B

16.9M

13M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.